A study of 185 Caucasian patients with NSCLC found that the frequency of CD16lowCD11b+CD14−HLA-DR−CD15+CD33+ PMN-MDSCs was significantly increased in the NSCLC patients compared with healthy controls [16]. The gene discussed is CD33; the disease is non-small cell lung carcinoma.